Skip to main content

Seroquel XR News

Severe QT Prolongation Common in Users of Antipsychotic Medications

TUESDAY, Jan. 23, 2024 – More than one in eight patients receiving quetiapine or haloperidol therapy appear to develop severe QT prolongation (SQTP), according to a study published online Jan. 14...

Ketamine Nasal Spray Shows Promise Against Tough-to-Treat Depression

THURSDAY, Oct. 5, 2023 – A nasal spray containing a ketamine derivative appears to beat one of the standard drugs used for people with difficult-to-treat depression, a new clinical trial has found....

FDA Approves Seroquel XR For Add-On Treatment of Major Depressive Disorder

WILMINGTON, Del., Dec. 4 /PRNewswire-FirstCall/ – AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved once-daily Seroquel XR (quetiapine fumarate) Extended...

FDA Medwatch Alert: Seroquel (quetiapine fumarate) - Apr 8, 2004

FDA and AstraZeneca notified healthcare professionals of revision to the WARNINGS section of labeling, describing the increased risk of hyperglycemia and diabetes in patients taking Seroquel. FDA has...

FDA Medwatch Alert: Seroquel (quetiapine fumarate) - Jun 12, 2002

AstraZeneca received reports of medication errors involving confusion between its atypical antipsychotic Seroquel (quetiapine fumarate), indicated for the treatment of schizophrenia, and Serzone...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Bipolar Disorder, Schizoaffective Disorder, Depression, Schizophrenia, Major Depressive Disorder

Seroquel XR patient information at Drugs.com